GET THE APP

Synergism Between Sequential Immunotherapy and Radiotherapy in A Malignant Pleural Mesothelioma Patient

Clinical Oncology: Case Reports.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Synergism Between Sequential Immunotherapy and Radiotherapy in A Malignant Pleural Mesothelioma Patient

Malignant Pleural Mesothelioma (MPM) is a highly invasive tumor that is linked to previous asbestos exposure. Combined multimodality treatment, i.e induction chemotherapy followed by surgery, is standard of care in highly selected patients. Platinum-doublet chemotherapy is the first choice for inoperable or advanced disease. There are no good recommendations for second-line treatment due to the lack of a clear survival benefit. Chest wall invasion is common and radiotherapy is used for pain control. We report the case of an MPM patient that showed a remarkable response through the combination of radiotherapy and immunotherapy. This case illustrates that despite failure of single-agent checkpoint inhibition, the combination of radiotherapy and immunotherapy has the potential to overcome checkpoint-inhibitor resistance in MPM.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations